Medaffcon operates actively in Denmark and Norway, even though our physical offices are in Finland and Sweden. In Denmark and Norway, a regional expert network complements our operations in place of a country-specific office.
Our services are designed for the Nordic market—Finland, Sweden, Denmark, and Norway. We support our clients through research, analyses, and market insights covering these countries.
Our scientific work builds on Nordic health registry data and long-term partnerships across the region. For example, we conduct Real-World Evidence (RWE) projects by utilising datasets from multiple Nordic countries.
Medaffcon has two physical offices: in Espoo, Finland, and in Stockholm, Sweden. Our ability to serve clients is not defined by the number of offices but by our broad Nordic capabilities. A Nordic presence does not require an office in every country.
Our networks and ways of working span national borders. Our teams collaborate closely with clients in all Nordic markets. Denmark is an essential part of our operational landscape, and we serve the Danish market from Finland and Sweden together with local experts and research organisations.
We currently have ongoing projects in Finland, Sweden, and Denmark, including Medical Affairs expert assignments. Across our projects, our specialists combine expertise in medicine, health economics, and data science to generate research and analyses on the real-world effectiveness of pharmaceuticals.
The Nordic countries offer exceptional health registries and research infrastructure by international standards. Data from different countries can be combined to form broader datasets that support more robust research.
Pharmaceutical companies increasingly operate in the Nordics as an integrated region—where research, data analysis, and market access strategies extend across several markets simultaneously. This regional model enables more efficient use of data, larger research populations, and faster responses to our clients’ needs.
Finland, Sweden, Denmark, and Norway have a combined population of 27.6 million. The region is a strong research environment thanks to similar healthcare systems and access to systematically collected national registry data. Consequently, findings from one country often translate well to others.
When data from multiple Nordic countries is combined, research results become broader and more generalisable across the region. We leverage this environment by offering a Nordic research approach: when needed, we design studies to cover several countries from the outset—removing the need for separate research projects in each market.
TTE is particularly valuable when there's a need to directly compare two treatments using real‑world data, especially when such comparisons have not been evaluated in randomised controlled trials (RCTs).
Doctoral researchers Yongbao Zhuang and Wenyang Shi are interns at the Medaffcon office in Stockholm.
While the majority of Medaffcon’s revenue comes from the pharmaceutical industry, the company’s activities are not limited only to commercial projects. At any given time, several academic projects may be ongoing.
CEO, Medaffcon Group
MSc (Tech.), B.Sc. (Econ.)
+358 44 251 7840
heikki.koski@medaffcon.com
Heikki Koski started as the CEO of Medaffcon in April 2024. Prior to this role, he worked as the Director of Service Business and Development at Tamro and as a board member of Tamro’s subsidiary, Medaffcon, since 2020. As a board member, Koski collaborated with CEO Jarmo Hahl in developing Medaffcon’s business. Koski continues to serve as a member of Tamro’s executive team.
Koski has extensive experience in service business, as well as in leading and developing digital business. At Tamro, he has been responsible for data services, e-commerce and service platform MyTamro, the health technology service Smila and Tamro’s business development, strategy processes. Prior to Tamro, Koski held various leadership roles at Finavia, including Airport Director and Chief Digital Officer. He has also worked as a consultant, entrepreneur and in product management at Nokia. Koski holds a Master’s degree in Industrial Engineering and Management and has also studied finance at Aalto University.
At Medaffcon, Koski brings strong expertise in service and digital business management and development, including the establishment of operating models and processes for expert organizations, strategy implementation and development, and internationalization.
In Medaffcon and the healthcare sector, Koski is motivated by the meaningfulness of the work. “It is crucial for every individual that the most effective treatments are made available. Technology accelerates development in the field, both in drug development and in building new ways of working. The significance and potential of health data are immense – the utilization of health data in the development and evaluation of treatment methods is constantly growing.”